Recombinant interleukin-2 (rIL-2) after autologous bone marrow transplantation (BMT): a pilot study in 19 patients

MLA

D, Blaise, et al. “Recombinant Interleukin-2 (RIL-2) after Autologous Bone Marrow Transplantation (BMT): A Pilot Study in 19 Patients.” European Cytokine Network, vol. 2, no. 2, Mar. 1991. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........6cfe76d258f9b9762a8a09e846a4e471&authtype=sso&custid=ns315887.

APA

D, B., P, V., D, O., A M, S., J, G., C N, P., M, A., M H, G., P, M., & C, J. (1991). Recombinant interleukin-2 (rIL-2) after autologous bone marrow transplantation (BMT): a pilot study in 19 patients. European Cytokine Network, 2(2).

Chicago

D, Blaise, Viens P, Olive D, Stoppa A M, Gabert J, Pourreau C N, Attal M, Gaspard M H, Mannoni P, and Jasmin C. 1991. “Recombinant Interleukin-2 (RIL-2) after Autologous Bone Marrow Transplantation (BMT): A Pilot Study in 19 Patients.” European Cytokine Network 2 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........6cfe76d258f9b9762a8a09e846a4e471&authtype=sso&custid=ns315887.